Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Locally Metastatic Malignant Neoplasm”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)UnknownNCT06110663
What this trial is testing

HS-10241 Combined With Almonertinib Versus Platinum-based Chemotherapy in Treatment of Advanced NSCLC With MET Amplification After Failure of EGFR-TKI Therapy

Who this might be right for
Non-Small Cell Lung Cancer
Jiangsu Hansoh Pharmaceutical Co., Ltd. 314
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07469306
What this trial is testing

Short-Course RT Plus CAPOX and Tislelizumab vs Long-Course CRT Plus Tislelizumab for Locally Advanced Rectal Cancer

Who this might be right for
Locally Advanced Rectal Cancer
Fujian Cancer Hospital 130
Testing effectiveness (Phase 2)Study completedNCT04212052
What this trial is testing

Split-course Hypofractionated Radiotherapy With Concurrent Chemotherapy in Locally Advanced Non-small Cell Lung Cancer

Who this might be right for
Non-small Cell Lung Cancer
Sun Yat-sen University 104
Testing effectiveness (Phase 2)Study completedNCT05507658
What this trial is testing

Tislelizumab Combined With XELOX as Neoadjuvant Therapy for G/GEJ Adenocarcinoma

Who this might be right for
Locally Advanced Gastric Adenocarcinoma
Xijing Hospital 28
Testing effectiveness (Phase 2)Study completedNCT00492206
What this trial is testing

Study of Cetuximab With Radiation Followed by Consolidation Chemotherapy for NSCLC

Who this might be right for
Non Small Cell Lung Cancer (NSCLC)
University of Pittsburgh 40
Testing effectiveness (Phase 2)Study completedNCT01267084
What this trial is testing

Assess the Potential Effects of Ketoconazole on the Pharmacokinetics of Trabectedin in Patients With Advanced Malignancies

Who this might be right for
Neoplasm Metastases
Janssen Research & Development, LLC 12
Testing effectiveness (Phase 2)Looking for participantsNCT04172532
What this trial is testing

Testing the Addition of a New Anti-cancer Drug, M3814 (Peposertib), to the Usual Radiotherapy in Patients With Locally Advanced Pancreatic Cancer

Who this might be right for
Locally Advanced Pancreatic AdenocarcinomaStage III Pancreatic Cancer AJCC v8
National Cancer Institute (NCI) 92
Testing effectiveness (Phase 2)Study completedNCT05444998
What this trial is testing

Neoadjuvant Inetetamab and Pyrotinib and Nab-paclitaxel for HER2+Breast Cancer

Who this might be right for
Breast Cancer
Xijing Hospital 20
Not applicableLooking for participantsNCT06630793
What this trial is testing

IMRT Versus IMPT With Concurrent Chemotherapy for Locally Advanced Anal Canal Cancer

Who this might be right for
Malignant Neoplasm of Anal Canal
Tata Memorial Centre 108
Testing effectiveness (Phase 2)Study completedNCT00445406
What this trial is testing

Bevacizumab and Doxorubicin Hydrochloride Liposome in Treating Women With Locally Recurrent or Metastatic Breast Cancer

Who this might be right for
Breast Cancer
Swiss Cancer Institute 43
Not applicableLooking for participantsNCT01050504
What this trial is testing

Collecting and Studying Blood and Tissue Samples From Patients With Locally Recurrent or Metastatic Prostate or Bladder/Urothelial Cancer

Who this might be right for
Localized Renal Pelvis and Ureter Urothelial CarcinomaMalignant Solid NeoplasmMetastatic Malignant Neoplasm in the Bone+8 more
University of Washington 1,500
Very early researchStudy completedNCT05678348
What this trial is testing

Pyrimethamine as an Inhibitor of NRF2 in HPV-unrelated Locally Advanced Head and Neck Squamous Cell Carcinoma

Who this might be right for
Head and Neck CancerCancer of the Head and Neck
Washington University School of Medicine 22
Testing effectiveness (Phase 2)Study completedNCT03110744
What this trial is testing

CDK4/6 Inhibition in Locally Advanced/Metastatic Chordoma

Who this might be right for
Chordoma
University Hospital Heidelberg 43
Testing effectiveness (Phase 2)UnknownNCT06202014
What this trial is testing

Phase II Study of Concurrent Radiotherapy With Envafolimab and Capecitabine in LAPC

Who this might be right for
Pancreatic CancerRadiotherapyEnvafolimab+1 more
Cancer Institute and Hospital, Chinese Academy of Medical Sciences 43
Large-scale testing (Phase 3)Looking for participantsNCT06156514
What this trial is testing

Evaluation of Concomitant Chemo-radiotherapy With Cisplatine vs Gemcitabin in Locally Advanced Cervicouterine Cancer

Who this might be right for
Locally Advanced Cervical CancerGemcitabineChemo-radiotherapy
National Institute of Cancerología 140
Not applicableUnknownNCT04502498
What this trial is testing

Preoperative Subclinical DVT Screening in Locally Advanced Bladder Cancer Patients Candidate for Radical Cystectomy.

Who this might be right for
Bladder Cancer Patients Candidate for Radical Cystectomy
Kasr El Aini Hospital 60
Testing effectiveness (Phase 2)Study completedNCT00004233
What this trial is testing

S9915 Triacetyluridine, Fluorouracil, and Leucovorin in Treating Patients With Unresectable, Locally Advanced, or Metastatic Cancer of the Esophagus or Stomach

Who this might be right for
Esophageal CancerGastric Cancer
SWOG Cancer Research Network 65
Testing effectiveness (Phase 2)UnknownNCT00005958
What this trial is testing

Combination Chemotherapy Plus Filgrastim in Treating Patients With Locally Recurrent or Advanced Urothelium Cancer

Who this might be right for
Bladder CancerTransitional Cell Cancer of the Renal Pelvis and Ureter
Amgen
Testing effectiveness (Phase 2)Ended earlyNCT00714948
What this trial is testing

Gemcitabine and Split-dose Cisplatin (GC) Plus Sorafenib in Chemotherapy-naïve Patients With Locally Advanced or Metastatic Urothelial Carcinoma

Who this might be right for
Bladder CancerURINARY BLADDER
Memorial Sloan Kettering Cancer Center 2
Early research (Phase 1)Study completedNCT02894944
What this trial is testing

Clinical Trial Phase I for Theragene in Combination With Chemotherapy for the Locally Advanced Pancreatic Cancer

Who this might be right for
Pancreatic Cancer
Seoul National University Hospital 9
Next Page